SLC5A2 and neoplasm: Although currently, the reports on the mechanistic aspect of SGLT2 inhibitors in suppressing tumor growth are limited, several studies revealed that suppression of glutamine metabolism and interference with several signaling cascades (such as PI3K/AMPK) might be crucial behind their anticancer effects [42].